Dietary trans-10, cis-12 conjugated linoleic acid reduces early glomerular enlargement and elevated renal cyclooxygenase-2 levels in young obese fa/fa zucker rats

Journal of Nutrition

Volumn 139, Issue 2, 2009, Pages 285-290

  Drury, Breanne ^a   Warford Woolgar, Lori J ^a   Herchak, Dielle J ^a   Bankovic Calic, Neda ^a   Crow, Gary ^a   Taylor, Carla G ^a   Zahradka, Peter ^a   Ogborn, Malcolm R ^a   Aukema, Harold M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; GLOMERULUS; KIDNEY FUNCTION; KIDNEY MASS; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; ZUCKER RAT; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FEEDING BEHAVIOR; METABOLISM; ORGAN SIZE; PATHOLOGY; WESTERN BLOTTING;

RATTUS;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CYCLOOXYGENASE 2; FEEDING BEHAVIOR; KIDNEY GLOMERULUS; LINOLEIC ACIDS, CONJUGATED; MALE; OBESITY; ORGAN SIZE; RATS; RATS, ZUCKER;

EID: 60249085577     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Pariza MW. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr. 2004;79:S1132-6.
2. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17:789-810.
3. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr. 2002;22:505-31.
4. Toomey S, McMonagle J, Roche HM. Conjugated linoleic acid: a functional nutrient in the different pathophysiological components of the metabolic syndrome? Curr Opin Clin Nutr Metab Care. 2006;9: 740-7.
5. Abrass CK. Overview, obesity: what does it have to do with kidney disease? J Am Soc Nephrol. 2004;15:2768-72.
6. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-74.
7. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Fitzpatrick-Wong S, Aukema HM. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int. 2003;64:1214-21.
8. Ogborn MR, Nitschmann E, Goldberg A, Bankovic-Calic N, Weiler HA, Aukema HM. Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease. Lipids. 2008;43:783-91.
9. Proctor SD, Kelly SE, Stanhope KL, Havel PJ, Russell JC. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes Obes Metab. 2007;9:87-95.
10. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J. Early events leading to renal injury in obese zucker (fatty) rats with type II diabetes. Kidney Int. 2000;57:167-82.
11. Kasiske BL, Cleary MP, O'Donnell MP, Keane WE Effects of genetic obesity on renal structure and function in the zucker rat. J Lab Clin Med. 1985;106:598-604.
12. O'Donnell MP, Kasiske BL, Cleary MP, Keane WE Effects of genetic obesity on renal structure and function in the zucker rat. II. Micro-puncture studies. J Lab Clin Med. 1985;106:605-10.
13. Toblli JE, DeRosa G, Cao G, Piorno P, Pagano P. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese zucker rats. Kidney Int. 2004;65:2343-59.
14. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26 Suppl 4:S21-4.
15. Dey A, Marie C, Kaesemeyer WH, Zaharis CZ, Stewart J, Pollock JS, Imig JD. Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci (Lond). 2004;107:561-70.
16. Komers R, Zdychova J, Cahova M, Kazdova L, Lindsley JN, Anderson S. Renal cyclooxygenase-2 in obese Zucker (fatty) rats. Kidney Int. 2005;67:2151-8.
17. Okumura M, Imanishi M, Yamashita T, Yamamura Y, Kim S, Iwao H, Tanaka S, Fujii S. Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. Life Sci. 2000;66:371-7.
18. Aukema HM, Adolphe J, Mishra S, Jiang J, Cuozzo FP, Ogborn MR. Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease. FASEB J. 2003;17:298-300.
19. Warford-Woolgar L, Peng CY, Shuhyta J, Wakefield A, Sankaran D, Ogborn M, Aukema HM. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased han:SPRD-cy rat kidneys. Am J Physiol Renal Physiol. 2006;290:F897-904.
20. Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, Natarajan R. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation. 2005;111:1962-9.
21. Li G, Barnes D, Butz D, Bjorling D, Cook ME. 10t,12c-conjugated linoleic acid inhibits lipopolysaccharide-induced cyclooxygenase expression in vitro and in vivo. J Lipid Res. 2005;46:2134-42.
22. Torres-Duarte AP, Vanderhoek JY. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim Biophys Acta. 2003; 1640: 69-76.
23. Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta. 2002;1580:150-60.
24. Truitt A, McNeill G, Vanderhoek JY. Antiplatelet effects of conjugated linoleic acid isomers. Biochim Biophys Acta. 1999;1438:239-46.
25. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
26. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998;244:678-82.
27. Noto A, Zahradka P, Yurkova N, Xie X, Nitschmann E, Ogborn MR, Taylor CG. Conjugated linoleic acid reduces hepatic steatosis, improves liver function, and favorably modifies lipid metabolism in obese insulin-resistant rats. Lipids. 2006;41:179-88.
28. Noto A, Zahradka P, Ryz NR, Yurkova N, Xie X, Taylor CG. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Metabolism. 2007;56: 142-51.
29. Noto A, Zahradka P, Yurkova N, Xie X, Truong H, Nitschmann E, Ogborn MR, Taylor CG. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats. Metabolism. 2007;56:1601-11.
30. Burr LL, Taylor CG, Weiler HA. Dietary conjugated linoleic acid does not adversely affect bone mass in obese fa/fa or lean Zucker rats. Exp Biol Med (Maywood). 2006;231:1602-9.
31. Ruth MR, Taylor CG, Zahradka P, Field CJ. Abnormal immune responses in fa/fa zucker rats and effects of feeding conjugated linoleic acid. Obesity (Silver Spring). 2008; 16:1770-9.
32. Sankaran D, Bankovic-Calic N, Peng CY, Ogborn MR, Aukema HM. Dietary flax oil during pregnancy and lactation retards disease progression in rat offspring with inherited kidney disease. Pediatr Res. 2006;60:729-33.
33. Weibel E. Practical methods for biological morphometry. In: Stereolog-ical methods. London: Academic Press; 1979. p. 41-5.
34. Hirose K, Osterby R, Nozawa M, Gundersen HJ. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 1982;21:689-95.
35. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43:305-10.
36. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150: 76-85.
37. Hwang SY, Taylor CG, Zahradka P, Bankovic-Calic N, Ogborn MR, Aukema HM. Dietary soy protein reduces early renal disease progression and alters prostanoid production in obese fa/fa Zucker rats. J Nutr Biochem. 2008;19:255-62.
38. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59: 1498-509.
39. Cheng HF, Harris RC. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr Pharm Des. 2005; 11:1795-804.
40. Hishinuma T, Tsukamoto H, Suzuki K, Mizugaki M. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids. 2001;65:191-6.
41. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002;106:1925-9.
42. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25:1516-21.